NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · Delayed Price · USD
0.203
0.008 (4.33%)
At close: May 17, 2022 3:56 PM
0.200
-0.002 (-1.185%)
After-hours:May 17, 2022 4:00 PM EDT
Market Cap10.41M
Revenue (ttm)9.24M
Net Income (ttm)-5.15M
Shares Out51.42M
EPS (ttm)-0.15
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume632,333
Open0.209
Previous Close0.194
Day's Range0.190 - 0.217
52-Week Range0.170 - 0.880
Beta3.40
AnalystsBuy
Price Target3.29 (+1,524.7%)
Earnings DateMay 12, 2022

About NBY

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne unde...

IndustryPharmaceuticals
IPO DateOct 26, 2007
CEOJustin Hall
Employees29
Stock ExchangeNYSEAMERICAN
Ticker SymbolNBY
Full Company Profile

Financial Performance

In 2021, NBY's revenue was $8.42 million, a decrease of -15.23% compared to the previous year's $9.93 million. Losses were -$5.82 million, -47.24% less than in 2020.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for NBY stock is "Buy." The 12-month stock price forecast is 3.29, which is an increase of 1,524.69% from the latest price.

Price Target
$3.29
(1,524.69% upside)
Analyst Consensus: Buy
Stock Forecasts

News

NovaBay Pharmaceuticals Reports First Quarter 2022 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three months ended March 31, 2022 and provides a business update. Financial res...

5 days ago - Business Wire

NovaBay Pharmaceuticals Expands Top-Selling DERMAdoctor Kakadu C and Calm Cool + Corrected Collections with New Anti-...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skin...

1 week ago - Business Wire

NovaBay Pharmaceuticals to Hold First Quarter 2022 Conference Call on May 12

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2022 after market close on T...

1 week ago - Business Wire

NovaBay Pharmaceuticals CEO Issues Letter to Stockholders

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow ...

3 weeks ago - Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to QVC® to Discuss DERMAdoctor's Eczema Treatment

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, ...

1 month ago - Business Wire

NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skin...

1 month ago - Business Wire

NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2021 and provides a business update. Fin...

1 month ago - Business Wire

NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and 12 months ended December 31, 2021 after market ...

1 month ago - Business Wire

DERMAdoctor Launches New HA Serum to Expand Calm Cool + Corrected Product Line

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skin...

2 months ago - Business Wire

NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin to Present DERMAdoctor Eczema Treatment as QVC® On-Air...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, ...

2 months ago - Business Wire

NovaBay Pharmaceuticals Engages Leading Chinese Marketing Firm to Drive Consumer Sales of DERMAdoctor Skincare Produc...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, ...

2 months ago - Business Wire

NovaBay Pharmaceuticals Announces Changes to Its Board of Directors

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifically formulated produ...

3 months ago - Business Wire

NovaBay Pharmaceuticals to Donate 2.5 Million KN95 Masks

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #KN95_masks--NovaBay Pharmaceuticals donates 2.5 million KN95 protective masks.

3 months ago - Business Wire

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”), a pharmaceutical company focused on developing and commercializing high-quality, sc...

3 months ago - Business Wire

NovaBay Pharmaceuticals Expands Its Eyecare Product Portfolio With the Launch of Lubricating Eye Drops for the Immedi...

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals launches Avenova Lubricating Eye Drops for the immediate relief of dry eye symptoms.

4 months ago - Business Wire

NovaBay Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing scientifically formulated and clinically prov...

4 months ago - Business Wire

NovaBay Pharmaceuticals Holds Special Meeting of Stockholders

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals adjourns it Special Meeting of Stockholders until January 14, 2022

4 months ago - Business Wire

DERMAdoctor's Calm Cool + Corrected Eczema Balm Receives National Eczema Association Seal of Acceptance

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #DERMAdoctor--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company focused on developing and commercializing high-quality, scientifi...

5 months ago - Business Wire

3 Hot Penny Stocks To Buy In December According To Insiders

Does Insider Buying Mean A Bullish Outlook For These Penny Stocks? The post 3 Hot Penny Stocks To Buy In December According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information...

Other symbols:ARCKPLT
5 months ago - PennyStocks

Hot Penny Stocks To Buy? 7 To Watch As African Variant Shakes Markets

Hot penny stocks to watch as new virus fears emerge on Black Friday. The post Hot Penny Stocks To Buy?

5 months ago - PennyStocks

NovaBay Pharmaceuticals Reports Third Quarter 2021 Financial Results

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2021 and provides a business update. ...

6 months ago - Business Wire

NovaBay Pharmaceuticals Closes DERMAdoctor Acquisition

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #DERMAdoctor--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the closing of the previously announced acquisition of DERMAdoctor, LLC. The Comp...

6 months ago - Business Wire

NovaBay Pharmaceuticals Closes $15.0 Million Private Placement

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #DERMAdoctor--NovaBay completes $15 million financing and expects to complete acquisition of DERMAdoctor, LLC on November 5, 2021.

6 months ago - Business Wire

NovaBay Pharmaceuticals Announces Pricing of $15.0 Million Private Placement

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay Pharmaceuticals announces pricing of $15 million private placement to fund acquisition of DERMAdoctor, LLC.

6 months ago - Business Wire

NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of D...

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call ...

7 months ago - Business Wire